AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

Researchers have suspected for some time that the link between our gut and brain plays a role in the development of Parkinson ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

This fall, the Montreal Neurological Institute and Hospital (The Neuro, at McGill University and the McGill University Health Centre) expects to introduce a previously unavailable form of treatment ...

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD ... may be more prone to treatment-emergent adverse ...

"We know that Parkinson's disease patients are at risk," Pronovost says, "so CMOs need to make sure they have a way to ...

"The best medication for Parkinson's will come from Israel. It will be a hybrid medication ... Integrative medicine, which is something we don't understand, is very, very important in treating any ...

The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...